North American Medical Corporation

What North American Medical Corporation does

North American Medical Corporation (NAM) is a privately held, family-owned medical device manufacturer founded in 2000 by Carlos and Grace Becerra in Marietta, Georgia. The company designs, manufactures, and sells FDA-cleared Class II non-surgical spinal decompression systems, principally the Accu-SPINA System, which exclusively administers its proprietary IDD Therapy (Intervertebral Differential Dynamics) treatment protocols. Core technology is anchored by six patents held by CEO Carlos Becerra, including the Oscillating Logarithmic Curve and the Oscillatory Signaling Sinusoidal Algorithm, paired with constant biofeedback systems capable of up to 256,000 force adjustments per second and a three-layered safety architecture. NAM has ISO 13485 and ISO 9001 certification, UL electrical safety listing, GUDID compliance, and a documented record of zero adverse events over 20+ years.

NAM generates revenue primarily through one-time hardware sales of new and factory-refurbished Accu-SPINA systems to chiropractic practices, medical specialists, physical therapy clinics, teaching hospitals, and rehabilitation centers, supplemented by managed-service support (remote diagnostics, calibration), and professional services for IDD Therapy provider certification and clinical training. The company sells through a sales-led direct channel domestically and via international distribution partners across Europe, Asia, and Africa, maintaining a global network of thousands of certified IDD Therapy providers. Recent strategic moves include the March 2026 exclusive partnership with Life University to establish an Outpatient Clinic and Educational Disc Center, expansion into knee therapy with the Accu-KNEE System, and development of the RejuvaHeart/RejuvaFlow cardiology and tissue-regeneration product line. NAM has no disclosed external institutional funding.

Name

North American Medical Corporation

Legal name

North American Medical Corporation

Website

https://namcorporation.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

North American Medical Corporation is a privately held, family-owned medical device manufacturer that designs and sells FDA-cleared Accu-SPINA spinal decompression systems and Accu-KNEE joint therapy systems, delivering its proprietary IDD Therapy protocols to chiropractors, physicians, physical therapists, and teaching hospitals worldwide.

Ownership category

akta.pro rank

Product category

Spinal Decompression Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Corrective Chiropractic & Spinal Decompression (HSADALAE), Chiropractic Rehabilitation & Therapeutic Exercise (HSADALAG)

Keywords

• Spinal decompression devices
• FDA cleared medical equipment
• Non-surgical decompression therapy
• IDD therapy systems
• Chiropractic treatment equipment

Headquarters

HQ city

Marietta

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Accu-SPINA System Sales: Sale of new FDA-cleared spinal decompression medical devices including Accu-SPINA System with IDD Therapy protocols and Accu-KNEE System. Premium medical-grade equipment with lifetime motor guarantee.
2. Pre-Owned/Refurbished Equipment Sales: Factory refurbished Accu-SPINA systems that have been carefully inspected, upgraded and quality tested. Includes GUDID labeling and factory support. Authorized refurbishment maintaining FDA compliance and quality standards.
3. Service and Support: Remote diagnostics, service, and calibration support for installed base. NAM provides ongoing maintenance solutions with minimal clinic downtime.
4. IDD Therapy Certification and Training: Training providers on IDD Therapy protocols and Accu-SPINA System operation. Provider certification program with ongoing clinical support.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

North American Medical Corporation designs, manufactures and sells the FDA-cleared Class II Accu-SPINA System — a computer-controlled medical device for non-surgical spinal decompression therapy using the proprietary IDD Therapy protocol — as well as the Accu-KNEE System for joint therapy. The company also sells factory-refurbished Accu-SPINA systems and provides remote diagnostics, calibration, and IDD Therapy certification training to licensed healthcare providers.

Product overview

North American Medical Corporation offers a portfolio of FDA-cleared medical devices for non-surgical spinal decompression and joint therapy. The core offering consists of the Accu-SPINA® System (the hardware platform) combined with IDD Therapy® treatment protocols (the proprietary software/treatment methodology) for spinal decompression, supplemented by the Accu-KNEE® System for joint treatment. The company also offers factory-refurbished devices and maintains a global provider network. All products are manufactured in ISO-certified facilities in Georgia and Puerto Rico, with over 1 million treatments performed worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Accu-SPINA® System: The primary medical device product line for non-surgical spinal decompression treatment, featuring IDD Therapy protocols and the patented Oscillating Logarithmic Curve technology.
• Accu-KNEE® System
• IDD Therapy®
• SPINA System™
• RejuvaFlow™

Products and services

• Accu-SPINA® System FDA-cleared Class II medical device for non-surgical spinal decompression therapy, featuring patented Oscillating Logarithmic Curve technology, IDD Therapy protocols, Constant Biofeedback (up to 256,000 adjustments/sec), Three-Layered Safety System, true-angle robotic positioning, dual synchronized bed columns with combined 8,000K force and 425lb load, networked multi-device patient data, and remote diagnostics. Sold to healthcare providers with a Lifetime Motor Guarantee.
• IDD Therapy® (Intervertebral Differential Dynamics) Proprietary FDA 510K-cleared treatment protocol delivered exclusively on the Accu-SPINA System using computer-directed sinusoidal oscillation and logarithmic waveforms for spinal decompression. Reported 86-92% success rates across multiple clinical studies; trademarked Intervertebral Differential Dynamics Therapy.
• Accu-KNEE® Joint Treatment System FDA-cleared Class II decompression device designed for patients with degenerative knee conditions, delivering controlled, stabilized therapy using technology extended from the Accu-SPINA platform.
• Pre-Owned / Refurbished Accu-SPINA Systems Factory-refurbished Accu-SPINA systems that have been carefully inspected, upgraded and quality tested, with full GUDID labeling and traceability and factory support. Sold as a more cost-effective alternative to new equipment while maintaining FDA compliance and quality.
• SPINA System™ Original back pain treatment device line that received FDA 510K clearance in July 2000, predecessor to the Accu-SPINA System.
• RejuvaHeart™ Cardiology treatment system developed by CEO Carlos Becerra designed to potentially outperform bypass surgery without surgery, part of the RejuvaFlow suite of tissue-regenerating technologies including treatments for erectile dysfunction.
• IDD Therapy Certification and Provider Training Training and certification of healthcare providers on IDD Therapy protocols and Accu-SPINA System operation, with ongoing clinical support. Delivered globally by Steve Johnson (National Trainer) across Asia, Europe, Ethiopia and other regions.
• Service, Remote Diagnostics and Calibration Support Remote diagnostics, online servicing, calibration and software updates for installed Accu-SPINA devices, with component-based expandable architecture enabling feature upgrades via download. Designed to minimize clinic downtime for the installed base.

Quantifiable outcome

• 92% success rate in avoiding surgery for 500+ patients referred for surgery who instead underwent IDD Therapy treatment
• +5 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Eleven partnerships are on record, tiered core and notable.

• Life UniversitycoreStrategic or Co-development Partner · 19 March 2026Exclusive partnership establishing new Outpatient Clinic and Educational Disc Center at Life University's Marietta, Georgia campus. Clinic integrates Accu-SPINA with IDD Therapy and Accu-KNEE systems as clinical training environment for chiropractic students and graduates under the Disc Centers of America model. Life University standardized on NAM's decompression platforms for its focused commitment to precision-based, protocol-driven care.
• Duke UniversitycoreStrategic or Co-development PartnerDr. C. Norman Shealy, Teaching Fellow in Surgery at Harvard and neurosurgeon at Duke University, collaborated with Carlos Becerra to develop IDD Therapy and Accu-SPINA System. Duke-affiliated research includes long-term effect analysis studies and clinical trials published in peer-reviewed journals.
• Emory UniversitycoreStrategic or Co-development PartnerEmory University School of Medicine conducted randomized controlled trial comparing IDD Therapy with exercise-based physical therapy. Dr. Schaufele, Harvard Medical School and Emory University, published comparative effectiveness studies showing greater pain relief with IDD Therapy.
• Disc Centers of AmericacoreStrategic or Co-development PartnerDr. Eric Kaplan, Founder of Disc Centers of America and Co-Chairman of International Advisory Board of Spinal Decompression, featured in provider testimonials. Model used for Life University clinical training implementation.
• International Advisory Board on Spinal DecompressioncoreStrategic or Co-development PartnerNAM established scientific advisory board with doctors and scientists to design treatment protocols specific to IDD Therapy. Advisory board meets monthly to share clinical observations and discuss patient outcomes with IDD Therapy Treatment patient groups.
• Mayo ClinicnotableTechnology or IntegrationDr. Ralph E. Gay from Mayo Clinic conducted research on stress in lumbar intervertebral discs during distraction, studying effects of distraction on disc pressure and rehabilitation potential.
• Parker UniversitynotableTechnology or IntegrationChiropractic university teaching IDD Therapy in postgraduate education since 2012. Dr. Eric Kaplan serves as Founder of Disc Centers of America and Co-Chairman of International Advisory Board of Spinal Decompression.
• Logan UniversitynotableTechnology or IntegrationConducted independent study on patient-based outcomes with Treatment on the Accu-SPINA System. Dr. Manella published evaluative study as part of clinical literature compendium.
• Sherman CollegenotableTechnology or IntegrationDr. Lucian Henry from Sherman College published observational study on effectiveness of non-surgical spinal decompression for neck and back pain in Journal of Novel Physiotherapy and Physical Rehabilitation.
• Guangxu HospitalnotableTechnology or IntegrationRehabilitation medicine department published case study citing Accu-SPINA with 92-93% success rates for cervical and lumbar spondylosis treatment.
• Harvard Medical SchoolcoreTechnology or IntegrationMultiple studies conducted by Harvard-affiliated researchers including Dr. Schaufele comparing IDD Therapy effectiveness versus exercise-based physical therapy. Published in American Journal of Physical Medicine & Rehabilitation.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Axiom Worldwide: Axiom Worldwide manufactures the DRX9000, one of the most widely recognized non-surgical spinal decompression devices competing directly with the Accu-SPINA System in chiropractic and spinal care clinics. Both companies target the same patient population (chronic back/neck pain, disc herniation) and the same provider channel with similar Class II FDA-cleared hardware.
• Saunders Group: Saunders Group manufactures clinical traction devices for cervical and lumbar spine, sold primarily to physical therapists and chiropractors. It represents a more mechanical (less algorithmic) peer to NAM's computer-controlled, IDD Therapy-driven decompression platform.
• Mettler Electronics: Mettler Electronics manufactures electrotherapeutic and ultrasonic medical devices for physical therapy and rehabilitation, including traction and decompression equipment. It sells into overlapping chiropractic and physical therapy channels with similar Class II FDA-cleared modalities.
• Hill Laboratories: Hill Laboratories manufactures the SpineMED decompression table and other spinal rehabilitation equipment, directly competing with NAM in the spinal decompression category. Both serve chiropractors, pain management specialists, and rehabilitation centers with computer-controlled decompression platforms.
• Spinal Designs International: Spinal Designs International developed the VAX-D (Vertebral Axial Decompression) system, an early direct competitor to NAM's IDD Therapy for non-surgical disc decompression. Both companies target the same chronic-pain patient segment with motorized decompression tables sold to chiropractors and pain specialists.

Broad incumbents

• DJO / Enovis: DJO Global (now part of Enovis) is a major orthopedic and rehabilitation device manufacturer with a broad portfolio including traction and decompression products under the Chattanooga brand. It competes with NAM across multiple rehabilitation categories but does not specialize in IDD-style algorithmic decompression.
• Chattanooga Group: Chattanooga Group (a brand within Enovis/DJO) is a long-established manufacturer of physical therapy, traction, and rehabilitation equipment. It overlaps with NAM's provider channels but offers a broader, more catalog-style portfolio rather than a specialized decompression platform.

Regional players

• Richway & Fuji Bio: Richway & Fuji Bio manufactures non-surgical spinal decompression devices and wellness equipment, primarily distributing within the chiropractic and alternative-care segment. It competes with NAM in the same end-customer base with similar algorithmic-decompression positioning.
• Richmar / Compass Health Brands: Richmar (now part of Compass Health Brands) manufactures clinical therapy devices including traction units used in physical therapy settings. It overlaps with NAM's rehab-channel GTM but is more diversified across modality categories and less specialized in spinal decompression.

Emerging players

• BTL Industries: BTL Industries manufactures non-invasive medical devices for physical therapy, rehabilitation, and pain management — including electromagnetic and focused shockwave therapies that partially overlap with NAM's spinal and joint decompression use cases. It serves overlapping provider segments but with different modality categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/iddtherapy
• Facebookfacebook.com/namcorporation
• LinkedInlinkedin.com/company/north-american-medical-corp

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about North American Medical Corporation